- Home
- OTLK vs RAY Comparison
OTLK vs RAY Comparison
Compare OTLK & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- RAY
- Stock Information
- Founded
- OTLK 2010
- RAY 1993
- Country
- OTLK United States
- RAY Hong Kong
- Employees
- OTLK N/A
- RAY N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- RAY Consumer Electronics/Appliances
- Sector
- OTLK Health Care
- RAY Consumer Discretionary
- Exchange
- OTLK Nasdaq
- RAY Nasdaq
- Market Cap
- OTLK 48.3M
- RAY 44.6M
- IPO Year
- OTLK 2016
- RAY 2024
- Fundamental
- Price
- OTLK $1.57
- RAY $1.21
- Analyst Decision
- OTLK Strong Buy
- RAY
- Analyst Count
- OTLK 5
- RAY 0
- Target Price
- OTLK $9.60
- RAY N/A
- AVG Volume (30 Days)
- OTLK 796.7K
- RAY 564.6K
- Earning Date
- OTLK 08-13-2025
- RAY 02-20-2025
- Dividend Yield
- OTLK N/A
- RAY N/A
- EPS Growth
- OTLK N/A
- RAY N/A
- EPS
- OTLK 0.83
- RAY 0.06
- Revenue
- OTLK N/A
- RAY $9,936,869.00
- Revenue This Year
- OTLK N/A
- RAY N/A
- Revenue Next Year
- OTLK $379.84
- RAY N/A
- P/E Ratio
- OTLK $1.91
- RAY $18.46
- Revenue Growth
- OTLK N/A
- RAY 28.52
- 52 Week Low
- OTLK $0.87
- RAY $0.86
- 52 Week High
- OTLK $9.25
- RAY $4.64
- Technical
- Relative Strength Index (RSI)
- OTLK 40.37
- RAY N/A
- Support Level
- OTLK $1.65
- RAY N/A
- Resistance Level
- OTLK $2.04
- RAY N/A
- Average True Range (ATR)
- OTLK 0.12
- RAY 0.00
- MACD
- OTLK -0.03
- RAY 0.00
- Stochastic Oscillator
- OTLK 2.13
- RAY 0.00
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About RAY Raytech Holding Limited Ordinary Shares
Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.